MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 196 filers reported holding MYRIAD GENETICS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $755 | -12.6% | 47,100 | +26.3% | 0.00% | -25.0% |
Q2 2023 | $864 | -66.7% | 37,300 | -66.7% | 0.00% | 0.0% |
Q1 2023 | $2,598 | +294.8% | 111,900 | +146.5% | 0.00% | +33.3% |
Q4 2022 | $658 | -99.9% | 45,400 | +4.4% | 0.00% | -25.0% |
Q3 2022 | $829,000 | -5.7% | 43,500 | -10.1% | 0.00% | 0.0% |
Q2 2022 | $879,000 | -21.0% | 48,400 | +9.5% | 0.00% | 0.0% |
Q1 2022 | $1,113,000 | -8.7% | 44,200 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $1,219,000 | -3.2% | 44,200 | +13.3% | 0.00% | -20.0% |
Q3 2021 | $1,259,000 | +0.2% | 39,000 | -5.1% | 0.01% | 0.0% |
Q2 2021 | $1,256,000 | +4.2% | 41,100 | +3.8% | 0.01% | 0.0% |
Q1 2021 | $1,205,000 | +20.0% | 39,600 | -22.0% | 0.01% | +25.0% |
Q4 2020 | $1,004,000 | +42.2% | 50,800 | -6.3% | 0.00% | +33.3% |
Q3 2020 | $706,000 | +12.2% | 54,200 | -2.3% | 0.00% | 0.0% |
Q2 2020 | $629,000 | +13.9% | 55,500 | +43.8% | 0.00% | 0.0% |
Q1 2020 | $552,000 | -47.5% | 38,600 | 0.0% | 0.00% | -25.0% |
Q4 2019 | $1,051,000 | -50.5% | 38,600 | -48.0% | 0.00% | -20.0% |
Q3 2019 | $2,124,000 | +130.4% | 74,200 | +123.5% | 0.01% | +25.0% |
Q2 2019 | $922,000 | -8.9% | 33,200 | +8.9% | 0.00% | -20.0% |
Q1 2019 | $1,012,000 | +14.2% | 30,500 | 0.0% | 0.01% | +25.0% |
Q4 2018 | $886,000 | -38.0% | 30,500 | -1.9% | 0.00% | -33.3% |
Q3 2018 | $1,430,000 | +6.6% | 31,100 | -13.4% | 0.01% | 0.0% |
Q2 2018 | $1,341,000 | +13.7% | 35,900 | -10.0% | 0.01% | +20.0% |
Q1 2018 | $1,179,000 | -6.7% | 39,900 | +8.4% | 0.01% | 0.0% |
Q4 2017 | $1,263,000 | -3.0% | 36,800 | +2.2% | 0.01% | -16.7% |
Q3 2017 | $1,302,000 | +26.7% | 36,000 | -9.5% | 0.01% | +20.0% |
Q2 2017 | $1,028,000 | +9.8% | 39,800 | -18.4% | 0.01% | +25.0% |
Q1 2017 | $936,000 | +5.2% | 48,800 | -8.6% | 0.00% | 0.0% |
Q4 2016 | $890,000 | -6.5% | 53,400 | +15.3% | 0.00% | 0.0% |
Q3 2016 | $952,000 | -22.6% | 46,300 | +15.2% | 0.00% | -20.0% |
Q2 2016 | $1,230,000 | -10.7% | 40,200 | +9.2% | 0.01% | -16.7% |
Q1 2016 | $1,377,000 | -9.3% | 36,800 | +4.5% | 0.01% | -14.3% |
Q4 2015 | $1,519,000 | +9.8% | 35,200 | -4.6% | 0.01% | 0.0% |
Q3 2015 | $1,383,000 | +1.5% | 36,900 | -8.0% | 0.01% | +16.7% |
Q2 2015 | $1,362,000 | – | 40,100 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
RK Capital | 384,900 | $16,612,000 | 2.90% |
Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |